Want to join the conversation?
$LLY's revenue by product had mixed results YoverY as Forteo, Strattera, Trajenta, and Animal Health revenues increased YoverY while Alimta, Humulin, Cymbalta, Zyprexa, and Evista reported declines in revenue; Evista declined significantly by 35%. On a YoverY basis, Humalog, Cialis, and Effient reported flat revenues compared to last year.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.